ArticleNature biomedical engineering2026

CCR5-targeted allogeneic gamma-delta CD19 chimeric antigen receptor T cells for HIV-associated B cell-malignancy immunotherapy.

Ángel Ramírez-Fernández et al.PubMed ↗Publisher ↗

No numbers read from the abstract.